Covered recipient · General Payments record
MICHELLE M LOUIS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$1,764.66
- Reported across 106 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $366.20 | 15 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| IDORSIA PHARMACEUTICALS US INC | $147.67 | 3 |
| ABBVIE INC. | $92.69 | 5 |
| Novo Nordisk AS | $44.36 | 2 |
| Abbott Laboratories | $35.66 | 2 |
| Acerta Pharma LLC | $18.31 | 1 |
| Lilly USA, LLC | $13.80 | 1 |
| Currax Pharmaceuticals LLC | $13.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.56 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018473871 | CMS |
| Abbott Laboratories | $14.10 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018500739 | CMS |
| ABBVIE INC. | $17.99 | 04/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997793631 | CMS |
| ABBVIE INC. | $14.50 | 07/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997793633 | CMS |
| ABBVIE INC. | $13.30 | 08/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997793635 | CMS |
| ABBVIE INC. | $25.70 | 08/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997793637 | CMS |
| ABBVIE INC. | $21.20 | 08/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997793639 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.31 | 05/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015733715 | CMS |
| Currax Pharmaceuticals LLC | $13.71 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 986429947 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $18.17 | 03/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034388335 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $110.08 | 04/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034388351 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $19.42 | 11/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034388343 | CMS |
| Lilly USA, LLC | $13.80 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031935109 | CMS |
| Novo Nordisk Inc | $19.50 | 03/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000840788 | CMS |
| Novo Nordisk Inc | $24.86 | 09/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000840803 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.